A prospective observation study of the dynamic monitoring of transcutaneous arterial blood oxygen saturation and carbon dioxide during bronchoscopy.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE
    • Publication Information:
      Publication: 2001- : London : BioMed Central Ltd.
      Original Publication: London : Current Science Ltd., c2000-
    • Subject Terms:
    • Abstract:
      Background and Aims: Because bronchoscopy is an invasive procedure, sedatives and analgesics are commonly administered, which may suppress the patient's spontaneous breathing and can lead to hypoventilation and hypoxemia. Few reports exist on the dynamic monitoring of oxygenation and ventilation during bronchoscopy. This study aimed to prospectively monitor and evaluate oxygenation and ventilation during bronchoscopy using transcutaneous arterial blood oxygen saturation and carbon dioxide.
      Methods: We included patients who required pathological diagnosis using fluoroscopic bronchoscopy at our hospital between March 2021 and April 2022. Midazolam was intravenously administered to all patients as a sedative during bronchoscopy, and fentanyl was administered in addition to midazolam when necessary. A transcutaneous blood gas monitor was used to measure dynamic changes, including arterial blood partial pressure of carbon dioxide (tcPCO 2 ), transcutaneous arterial blood oxygen saturation (SpO 2 ), pulse rate, and perfusion index during bronchoscopy. Quantitative data of tcPCO 2 and SpO 2 were presented as mean ± standard deviation (SD) (min-max), while the quantitative data of midazolam plus fentanyl and midazolam alone were compared. Similarly, data on sex, smoking history, and body mass index were compared. Subgroup comparisons of the difference (Δ value) between baseline tcPCO 2 at the beginning of bronchoscopy and the maximum value of tcPCO 2 during the examination were performed.
      Results: Of the 117 included cases, consecutive measurements were performed in 113 cases, with a success rate of 96.6%. Transbronchial lung biopsy was performed in 100 cases, whereas transbronchial lung cryobiopsy was performed in 17 cases. Midazolam and fentanyl were used as anesthetics during bronchoscopy in 46 cases, whereas midazolam alone was used in 67 cases. The median Δ value in the midazolam plus fentanyl and midazolam alone groups was 8.10 and 4.00 mmHg, respectively, indicating a significant difference of p < 0.005. The mean ± standard deviation of tcPCO 2 in the midazolam plus fentanyl and midazolam alone groups was 44.8 ± 7.83 and 40.6 ± 4.10 mmHg, respectively. The SpO 2 in the midazolam plus fentanyl and midazolam alone groups was 94.4 ± 3.37 and 96.2 ± 2.61%, respectively, with a larger SD and greater variability in the midazolam plus fentanyl group.
      Conclusion: A transcutaneous blood gas monitor is non-invasive and can easily measure the dynamic transition of CO 2 . Furthermore, tcPCO 2 can be used to evaluate the ventilatory status during bronchoscopy easily. A transcutaneous blood gas monitor may be useful to observe regarding respiratory depression during bronchoscopy, particularly when analgesics are used.
      (© 2024. The Author(s).)
    • References:
      Yserbyt J, De Maeyer N, Dooms C, Testelmans D, Muylle I, Bruyneel M, Ninane V. The feasibility of tracheal oxygen supplementation during flexible bronchoscopy. Respiration. 2016;92:48–52. (PMID: 10.1159/00044751927355371)
      Purugganan RV. Intravenous anesthesia for thoracic procedures. Curr Opin Anaesthesiol. 2008;21:1–7. (PMID: 10.1097/ACO.0b013e3282f2bb8f18195601)
      Grendelmeier P, Tamm M, Jahn K, Pflimlin E, Stolz D. Flexible bronchoscopy with moderate sedation in COPD: a case-control study. Int J Chron Obstruct Pulmon Dis. 2017;12:177–87. (PMID: 10.2147/COPD.S119575281158415221558)
      Chhajed PN, Heuss LT, Tamm M. Cutaneous carbon dioxide monitoring in adults. Curr Opin Anaesthesiol. 2004;17:521–5. (PMID: 10.1097/00001503-200412000-0001417031089)
      Kodali BS. Capnography outside the operating rooms. Anesthesiology. 2013;118:192–201. (PMID: 10.1097/ALN.0b013e318278c8b623221867)
      Sanders MH, Kern NB, Costantino JP, Stiller RA, Strollo PJ Jr, Studnicki KA, Coates JA, Richards TJ. Accuracy of end-tidal and transcutaneous PCO2 monitoring during sleep. Chest. 1994;106:472–83. (PMID: 10.1378/chest.106.2.4727774323)
      Eberhard P. The design, use, and results of transcutaneous carbon dioxide analysis: current and future directions. Anesth Analg. 2007;105:S48-s52. (PMID: 10.1213/01.ane.0000278642.16117.f818048898)
      Windisch W, Storre JH, Sorichter S, Virchow JC Jr. Comparison of volume- and pressure-limited NPPV at night: a prospective randomized cross-over trial. Respir Med. 2005;99:52–9. (PMID: 10.1016/j.rmed.2004.05.00915672849)
      Hirabayashi M, Fujiwara C, Ohtani N, Kagawa S, Kamide M. Transcutaneous PCO2 monitors are more accurate than end-tidal PCO2 monitors. J Anesth. 2009;23:198–202. (PMID: 10.1007/s00540-008-0734-z19444557)
      Hinkelbein J, Floss F, Denz C, Krieter H. Accuracy and precision of three different methods to determine Pco2 (Paco2 vs. Petco2 vs. Ptcco2) during interhospital ground transport of critically ill and ventilated adults. J Trauma. 2008;65:10–18.
      Casati A, Squicciarini G, Malagutti G, Baciarello M, Putzu M, Fanelli A. Transcutaneous monitoring of partial pressure of carbon dioxide in the elderly patient: a prospective, clinical comparison with end-tidal monitoring. J Clin Anesth. 2006;18:436–40. (PMID: 10.1016/j.jclinane.2006.02.00716980160)
      Fruchter O, Carmi U, Ingenito EP, Refaeli Y, Kramer MR. Transcutaneous carbon dioxide in severe COPD patients during bronchoscopic lung volume reduction. Respir Med. 2011;105:602–7. (PMID: 10.1016/j.rmed.2010.11.00521115237)
      Minami D, Murakami E, Shibata Y, Nakamura K, Kishino T, Takigawa N, Onishi K, Takigawa Y, Shimonishi A, Kudo K, et al. End-tidal capnographic monitoring during flexible bronchoscopy under fentanyl and midazolam sedation. Ann Palliat Med. 2021;10:8665–71. (PMID: 10.21037/apm-21-100934379981)
      Prakash UB, Offord KP, Stubbs SE. Bronchoscopy in North America: the ACCP survey. Chest. 1991;100:1668–75. (PMID: 10.1378/chest.100.6.16681959412)
      Pickles J, Jeffrey M, Datta A, Jeffrey AA. Is preparation for bronchoscopy optimal? Eur Respir J. 2003;22:203–6. (PMID: 10.1183/09031936.03.0011830212952248)
      Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, Mandal S, Martin J, Mills J, Navani N, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax. 2013;68(Suppl 1):i1–44. (PMID: 10.1136/thoraxjnl-2013-20361823860341)
      Wahidi MM, Jain P, Jantz M, Lee P, Mackensen GB, Barbour SY, Lamb C, Silvestri GA. American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients. Chest. 2011;140:1342–50. (PMID: 10.1378/chest.10-336122045879)
      Stolz D, Chhajed PN, Leuppi JD, Brutsche M, Pflimlin E, Tamm M. Cough suppression during flexible bronchoscopy using combined sedation with midazolam and hydrocodone: a randomised, double blind, placebo controlled trial. Thorax. 2004;59:773–6. (PMID: 10.1136/thx.2003.019836153338541747138)
      Chhajed PN, Glanville AR. Management of hypoxemia during flexible bronchoscopy. Clin Chest Med. 2003;24:511–6. (PMID: 10.1016/S0272-5231(03)00050-914535223)
      British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax. 2001;56(Suppl 1):i1-21.
    • Contributed Indexing:
      Keywords: Bronchoscopy; Dynamic monitoring; Saturation of percutaneous oxygen (SpO2); Transcutaneous carbon dioxide partial pressure (tcPCO2)
    • Accession Number:
      142M471B3J (Carbon Dioxide)
      UF599785JZ (Fentanyl)
      0 (Hypnotics and Sedatives)
      R60L0SM5BC (Midazolam)
      S88TT14065 (Oxygen)
    • Publication Date:
      Date Created: 20241005 Date Completed: 20241005 Latest Revision: 20241109
    • Publication Date:
      20241109
    • Accession Number:
      PMC11456238
    • Accession Number:
      10.1186/s12931-024-02990-0
    • Accession Number:
      39369209